The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1140
ISSUE1140
September 30, 2002
Escitalopram (Lexapro) for Depression
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Escitalopram (Lexapro) for Depression
September 30, 2002 (Issue: 1140)
Escitalopram (Lexapro - Forest), the active S-enantiomer of racemic citalopram (Celexa - Forest), a selective serotonin reuptake inhibitor (SSRI), was recently approved by the FDA for treatment of depression. The manufacturer plans to stop promoting...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.